Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.0028 | 0.9 |
mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.9 |
mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |
mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |